Specific antagonists for glucose-dependent insulinotropic polypeptide (gip) -> Monitor Keywords

Site News |

Monitor Keywords |

Monitor Archive |

Organizer |

Account Info |

Specific antagonists for glucose-dependent insulinotropic polypeptide (gip)

USPTO Application #: 20070173455
Title: Specific antagonists for glucose-dependent insulinotropic polypeptide (gip)
Abstract: In one embodiment, this invention provides an antagonist of glucose-dependent insulinotropic polypeptide (GIP) consisting essentially of a 24 amino acid polypeptide corresponding to positions 7-30 of the sequence of GIP. In another embodiment, this invention provides a method of preventing and treating obesity and non-insulin dependent diabetes mellitus (Type II) in a patient comprising administering to the patient an antagonist of glucose-dependent insulinotropic polypeptide (GIP). In yet another embodiment, this invention provides a method of improving glucose tolerance in a mammal comprising administering to the mammal an antagonist of glucose-dependent insulinotropic polypeptide (GIP). (end of abstract)
USPTO Applicaton #: 20070173455 - Class: 514013000 (USPTO)
Related Patent Categories: Drug, Bio-affecting And Body Treating Compositions, Designated Organic Active Ingredient Containing (doai), Peptide Containing (e.g., Protein, Peptones, Fibrinogen, Etc.) Doai, Cyclopeptides, 16 To 24 Peptide Repeating Units In Known Peptide Chain

[The Full Description and Claims for this patents is not available from FreshPatents.com temporarily]

We apologize for the inconvenience:
Normally the full description and claims of the patent you are viewing (20070173455, Specific antagonists for glucose-dependent insulinotropic polypeptide (gip)) would be available here (see sample below). However, this information from this patent is currently not available from our database.

Most likely, this is a temporary technical issue. We have logged this message and will attempt to resolve the issue. Please check back again soon.

Click on the above for other options relating to this Specific antagonists for glucose-dependent insulinotropic polypeptide (gip) patent application.
###

How KEYWORD MONITOR works... a FREE service from FreshPatents
1. Sign up (takes 30 seconds). 2. Fill in the keywords to be monitored.
3. Each week you receive an email with patent applications related to your keywords.
Start now! - Receive info on patent apps like Specific antagonists for glucose-dependent insulinotropic polypeptide (gip) or other areas of interest.
###

Previous Patent Application:
Preptin fragments and methods of use
Next Patent Application:
Tau-conotoxin peptides
Industry Class:
Drug, bio-affecting and body treating compositions

###

Design/code © 2008 FreshContext LLC/Freshpatents.com. Website Terms and Conditions - Also read: About this Page
Patent data source: patents published by the United States Patent and Trademark Office (USPTO)
Information published here is for research/educational purposes only (and in conjunction with our Keyword Monitor) and is not meant to be used in place of the full USPTO patent document/images or a comprehensive patent archive search. Complete official applications are on file at the USPTO and often contain additional data/images (Freshpatents is currently text-only). FreshPatents.com is not affiliated with or endorsed by the USPTO or firms/individuals or products/designs/ideas related to listed patents.

FreshPatents.com Support
Thank you for viewing the Specific antagonists for glucose-dependent insulinotropic polypeptide (gip) patent info.
IP-related news and info

Results in 0.04792 seconds

Other interesting Feshpatents.com categories:
Novartis , Pfizer , Philips , Polaroid , Procter & Gamble ,